In the evolving field of cell biology and tissue engineering, the vitronectin peptide has emerged as a significant area of interest for researchers focused on substrate development and cellular interaction. As someon PluriSTEM™ Recombinant Vitronectin is an effective xeno-free alternative to matrigel™ and has been validated to successully culture human ES and iPS cells using e deeply invested in the technical aspects of laboratory research and peptide synthesis, I have spent considerable time analyzing how fragments of this multifunctional glycoprotein can be utilized to optimize experimental environments.
Understanding the Vitronectin Molecule
Vitronectin is a complex, 70 kDa glycoprotein found in both serum and the extracellular matrix (ECM). It is a well-documented member of the hemopexin family and serves as a vital c VTN/Vitronectin His Tag Protein, Human ; 表达宿主. HEK293 ; 分子量. 72-75kDa ; 纯度. ＞95% by SDS-PAGE ; 内毒素含量. <0.1EU/μg ; 标记. Unconjugated ell adhesion and spreading factor. Because it is essential for maintaining the integrity and normal function of tissues, it has become a gold standard for those looking to create a defined Vitronectin is a monomeric glycoprotein used to promote cell attachment, migration, proliferation and differentiation in a broad number of cell lines and types. environment for cell cultures.
When we talk about the vitronectin peptide, we are generally referring to a fragment or bioactive sequence derived from the vitronectin protein itself. These smaller, synthetic versions are often preferred in controlled laboratory settings because they offer a more predictable, by SK Min · 2018 · Cited by 79 — A new bioactive core vitronectin-derived peptide (VnP-16) promoted bone formation by accelerating osteoblast differentiation and activity. animal-free, synthetic, flexible vitronectin-based peptide substrate compared to the full-length protein extracted from biological sources.
Key Research Applications
The versatility of these peptides is reflected in how they are currently being applied in high-level research:
* Cell Differentiation and Adhesion: Researchers often utilize these fragments to provide a new defined coating material for the differentiation of various cell types, including oligodendrocytes (ODs) from human pluripotent stem cells.
* Osteoblast Activity: Studies have shown that specific bioactive core sequences, such as VnP-16, have promoted bone formation by accelerating osteoblast differenti Vitronectin Products ation and activity, offering a fascinating look at how localized signaling can impact tissue-level development.
* Scalable Substrates: The development of a robust vitronectin-derived peptide has proven essential for the scalable long-term expansion of stem cells. By utilizing an easy-to-use, xeno-free, defined, recombinant human ECM, laboratories can achieve more consistent results without the variability associated with undefined serum-based reagents.
Technical Specifications and Structural Considerations
From a structural perspective, the VTN (Vitronectin) gene encodes a protein that is synthesized in the liver and secreted into the bloodstream. It is well-known that the vitronectin peptide, such as the [351–359] h-Vitr Vitronectin in health and disease: Mechanisms and therapeutic onectin sequence, can be used to VTN/Vitronectin His Tag Protein, Human-抗体 functionalize surfaces like 3D-printed PEEK disks to improve biocompatibility.
When sourcing these materials, it is important to note the specific characteristics of the peptide. For instance, the Vitronectin (367-378) fragment is frequently studied for its role in cell growth and its interaction with integrins. Whether you are working with a VTN/Vitronectin His Tag Protein or a specific amino acid fragment, the purity and the specific sequence design are paramount to the success of the experiment.
Observations on Laboratory Usage
In my own experience with these compounds, the transition toward a synthetic, xeno-free alternative has been a game-changer. By using a fragment that mimics the native protein, we eliminate the risks associated with xenogenic contaminants. It is fascinating to see how a simple sequence—a fragment or bioactive sequence derived from the vitronectin protein—can replicate the complex adhesive properties of the native molecule.
Furthermore, because vitronectin is a member of the pexin family, its structural stability is generally high, making it an excellent candidate for Subcutaneous injection of a cyclic peptide antagonist coating plates or flasks. Whether you are investigating the role of VTN as a plasma glycoprotein or attempting to induce specific cellular pathways, the precision offered by these engineered peptides is unmatched.
Conclusion
The study of the vitronectin peptide continues to push the boundaries of what is possible in regenerative research. By isolating the functional characteristics of this glycoprotein, we are able to create more refined, reproducible, and efficient experimental models. As research progresses, the ability to tailor these sequences to specific cellular needs will undoubtedly remain a cornerstone for those focused on the mechanics of cell adhesion and the fundamental architecture of the extracellular matrix.